Vaxcyte, Inc.
PCVX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001649094
Insider trades, last 90 days
0 buys · 8 sells
- Sold $3.68M
- Open-market purchases (P) and sales (S), counted by Form 4 filing.
13F holders, Q2 2026
331
- −5 vs. Q1 2026
- Total value $9.73B
Superinvestors holding PCVX
1
- At the end of Q2 2026
Price chart
Latest insider trades
View all: Latest insider tradesOpen-market purchases and sales by PCVX insiders, newest first.
| Filed (ET) | Trade date | Insider | Transaction | Shares | Avg price | Value | Shares after | Holding change | Filing |
|---|---|---|---|---|---|---|---|---|---|
| Sep 9, 20265:46 PM ET | Sep 4 – Sep 9, 2026 | Wassil JimEVP, Chief Scientific Ofc, COO | SSaleCommon Stock | −2.72K | $60.3547 | −$163.86K | 145.44K | −1.8% | SEC |
| Sep 2, 20267:58 PM ET | Sep 1, 2026 | Wassil JimCHIEF OPERATING OFFICER | SSaleCommon Stock | −3.48K | $61.0732 | −$212.35K | 155.04K | −2.2% | SEC |
| Aug 5, 20267:01 PM ET | Aug 5, 2026 | Dhaliwal Harpreet S.Chief Technical Ops Officer | SSaleCommon Stock | −17K | $55.004 | −$935.07K | 76.76K | −18.1% | SEC10b5-1 |
| Aug 5, 20264:59 PM ET | Aug 3, 2026 | Wassil JimCHIEF OPERATING OFFICER | SSaleCommon Stock | −2.25K | $53.8644 | −$121.19K | 157.54K | −1.4% | SEC10b5-1 |
| Aug 5, 20264:58 PM ET | Aug 3, 2026 | GUGGENHIME ANDREWPRESIDENT AND CFO | SSaleCommon Stock | −10K | $53.8879 | −$538.88K | 105.18K | −8.7% | SEC10b5-1 |
Top 5 13F holders, Q2 2026
View all: Top 5 13F holders, Q2 2026The largest institutional positions in PCVX at the end of Q2 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| FMR LLC | 20,852,907 | $1.21B | 0.05% | +4,360,046+26.4% | Added |
| Jupiter Topco LLC | 17,965,847 | $1.04B | 0.43% | +17,965,847 | New |
| T. Rowe Price Investment Management, Inc. | 12,207,450 | $709.62M | 0.47% | +81,433+0.7% | Added |
| BlackRock, Inc. | 12,068,129 | $701.52M | 0.01% | +1,096,313+10.0% | Added |
| RA CAPITAL MANAGEMENT, L.P. | 11,474,599 | $667.02M | 5.80% | 00.0% | Unchanged |